Nippon Shinyaku Co Ltd ADR (NPPNY PINK) stock market data APIs
$5.9419
0(0%)
as of July 3, 2026
Try our APIs with
free plan!
Nippon Shinyaku Co Ltd ADR Financial Data Overview
Price chart is built with
Anychart
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and RGX-121 for the treatment of mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
Prev. Close
5.9419
Open
5.9419
High
5.9419
Low
5.9419
52 wk Range
4.8657-9.1469
Market Cap
1 618 M
P/E Ratio
8.8235
Shares Outstanding
270 M
Revenue
170 771 M
EPS
0.0909
Dividends (Yield)
0.0325
Beta
-0.331
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Nippon Shinyaku Co Ltd ADR data using free add-ons & libraries
Get Nippon Shinyaku Co Ltd ADR Fundamental Data
Nippon Shinyaku Co Ltd ADR Fundamental data includes:
- Net Revenue: 170 771 M
- EBITDA: 39 602 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Nippon Shinyaku Co Ltd ADR Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Nippon Shinyaku Co Ltd ADR News
New
Nippon Shinyaku and Elixirgen Therapeutics Enter Option Agreement for Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy
PARAMUS, N.J., June 26, 2026 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma; Headquarters, Paramus, NJ; President, Yukiteru Sugiyama) announced today that its parent company, Nippon Shinyaku Co., Ltd. (Ni...
Elixirgen Therapeutics and Nippon Shinyaku Enter into an Option Agreement for the Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy
Elixirgen Therapeutics, Inc. BALTIMORE, June 26, 2026 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company developing treatments for rare diseases and aging-associ...
NS Pharma Parent Company, Nippon Shinyaku, Announces Sponsored Research Agreement with Boston Children's Hospital
PARAMUS, N.J., June 23, 2026 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma; Headquarters: Paramus, New Jersey; President: Yukiteru Sugiyama) announced today that its parent company, Nippon Shinyaku Co., ...
Capricor Lawsuit Puts Duchenne Therapy Launch Plans And Valuation In Focus
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Capricor Therapeutics (NasdaqGS:CAPR) has filed a lawsuit t...
Get Nippon Shinyaku Co Ltd ADR fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
